Literature DB >> 20070700

Cytomegalovirus in solid organ transplant recipients.

A Humar1, D Snydman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20070700     DOI： 10.1111/j.1600-6143.2009.02897.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  62 in total

Review 1.  Management of cytomegalovirus infection in solid organ transplantation.

Authors:  Camille N Kotton
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

2.  Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective.

Authors:  Colleen S Kraft; Wendy S Armstrong; Angela M Caliendo
Journal:  Clin Infect Dis       Date:  2012-03-12       Impact factor: 9.079

Review 3.  Cytomegalovirus infection in liver transplant recipients: updates on clinical management.

Authors:  Jasmine Riviere Marcelin; Elena Beam; Raymund R Razonable
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

4.  Infections in liver transplant recipients.

Authors:  Fabian A Romero; Raymund R Razonable
Journal:  World J Hepatol       Date:  2011-04-27

Review 5.  Risk of cytomegalovirus transmission by blood products after solid organ transplantation.

Authors:  Deborah Jebakumar; Patti Bryant; Walter Linz
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-04-23

Review 6.  New developments in the management of cytomegalovirus infection after solid organ transplantation.

Authors:  Albert J Eid; Raymund R Razonable
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

Review 7.  [Intensive care treatment before and after liver transplantation].

Authors:  I Graziadei
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-08-22       Impact factor: 0.840

Review 8.  Infections after orthotopic liver transplantation.

Authors:  Mark Pedersen; Anil Seetharam
Journal:  J Clin Exp Hepatol       Date:  2014-07-24

Review 9.  Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

Authors:  Daniel S Owers; Angela C Webster; Giovanni F M Strippoli; Kathy Kable; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

10.  A Physiologically Based Pharmacokinetic Model for Ganciclovir and Its Prodrug Valganciclovir in Adults and Children.

Authors:  V Lukacova; P Goelzer; M Reddy; G Greig; B Reigner; N Parrott
Journal:  AAPS J       Date:  2016-07-22       Impact factor: 4.009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.